Article info

Download PDFPDF

Original research
Adverse events of special interest in clinical trials of rheumatoid arthritis, psoriatic arthritis, ulcerative colitis and psoriasis with 37 066 patient-years of tofacitinib exposure

Authors

  1. Correspondence to Dr Hernan Valdez; Hernan.valdez{at}pfizer.com
View Full Text

Citation

Burmester GR, Nash P, Sands BE, et al
Adverse events of special interest in clinical trials of rheumatoid arthritis, psoriatic arthritis, ulcerative colitis and psoriasis with 37 066 patient-years of tofacitinib exposure

Publication history

  • Received January 20, 2021
  • Revision received April 30, 2021
  • Accepted May 4, 2021
  • First published May 27, 2021.
Online issue publication 
May 27, 2021

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.